dronabinol has been researched along with clonazepam in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Elian, AA; Hackett, J | 1 |
| Dempsey, SK; Gray, TR; Kelly, AT; Lee, D; Stout, P | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Barkholtz, H; Miles, A; Pieters, R; Sanders, T; Savage, T | 1 |
1 review(s) available for dronabinol and clonazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for dronabinol and clonazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A polydrug intoxication involving methoxetamine in a drugs and driving case.
Topics: Chromatography, Gas; Chromatography, Liquid; Clonazepam; Cyclohexanones; Cyclohexylamines; Diphenhydramine; Driving Under the Influence; Dronabinol; GABA Modulators; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2014 |
A Comparison of High Drug Concentrations in Impaired Driving and Postmortem Casework in Harris County, TX.
Topics: Automobile Driving; Clonazepam; Driving Under the Influence; Dronabinol; Ethanol; Fentanyl; Hydrocodone; Methamphetamine; Oxycodone; Substance Abuse Detection | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin.
Topics: Amphetamine; Analgesics, Opioid; Benzodiazepines; Clonazepam; Cocaine; Diazepam; Dronabinol; Fentanyl; Humans; Methamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection; Wisconsin | 2022 |